Peer-influenced content. Sources you trust. No registration required. This is HCN.

Essential Medical Reading

Your Weekly Roundup of the Most-Read News and Clinical References from Your Peers

Journal of Clinical Oncology

Phase 2 trial in oeso-gastric adenocarcinoma (OSA) showed pathologic complete response in 59% of patients. Data update expected at ASCO 2022.

Oncology, Medical May 10th 2022

Northwestern Medicine

A combination of BET inhibitor with anti-PD-1 shows promise in murine model

Oncology, Medical May 10th 2022

Journal of Clinical Oncology

Unique anti-PD-L1 plus chemotherapy improves OS vs. chemotherapy alone as 1st line in esophageal cancer

Oncology, Medical May 10th 2022

MashupMD

Nose Spray Vaccines Could Quash COVID Virus Variants

Allergy & Immunology May 10th 2022

JAMA Network

Comparison of Home Antigen Testing w. RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection

Allergy & Immunology May 10th 2022

Tags: COVID-19

“There’s a Real Risk There”: Cannabis Use Exacerbates Depression

Family Medicine/General Practice May 10th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form